Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Thrombocytopenia 1Neutropenia 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Anemia 1

Interventions

Cytarabine 39Busulfan 15Idarubicin 14Cyclophosphamide 13Mitoxantrone 12Filgrastim 12Etoposide 12fludarabine phosphate 11Peripheral Blood Stem Cell Transplantation 11Daunorubicin 9Methotrexate 8Cyclosporine 8Tacrolimus 7Whole-Body Irradiation 5Mycophenolic Acid 5Clofarabine 5Cladribine 5Biopsy 5Azacitidine 5Arsenic Trioxide 5Antilymphocyte Serum 5Radiotherapy 4Gemtuzumab 4Flow Cytometry 4Decitabine 4Cyclosporins 4venetoclax 3pegylated granulocyte colony-stimulating factor 3Topotecan 3Injections 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Monocytic, Acute × leridistim × Clear all
NCT00004215 2013-06-19

Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Classical hematologyOther hematologic neoplasm

Anemia, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Thrombocytopenia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡